Category Archives: Dr. Peter Anton

  1. PRESS RELEASE: Tenofovir Gel Provides High Level of Protection Against HIV in Rectal Tissue

    via Microbicide Trials Network [The abstract, RMP-02/MTN-006: A Phase I Placebo Controlled Trial of Rectally Applied 1% Vaginal Tenofovir Gel with Comparison to Oral Tenofovir Disoproxil Fumarate, is being presented at a scientific session at CROI 2011 TODAY from 10 a.m. – 12:15 p.m. ET.] Strongest effect seen in tissue taken from participants after one week of Read More >>

    CROI, Dr. Ian McGowan, Dr. Peter Anton, MTN, NIH, rectal microbicide, Tenofovir
  2. NEW Rectal Microbicide Trial is Recruiting

    Official Title: “A Two-site, Phase 1, Partially-blinded, Placebo-controlled Safety, Acceptability and Pharmacokinetic Trial of Topical, Vaginally-formulated Tenofovir 1% Gel Applied Rectally Compared With Oral 300 mg Tenofovir Disoproxil Fumarate in HIV-1 Seronegative Adults” Clinical Trial Phase: Phase 1 | Start Date: September 2009 Overall Status: Recruiting Estimated Enrollment: 18 To date, the majority of microbicide research has Read More >>

    anal sex, CONRAD, Dr. Peter Anton, gay men, MSM, new prevention technologies, NIH, rectal microbicide, research, Tenofovir, women
  3. IRMA Exclusive: A Preview of New Rectal Microbicide Safety Studies

    IRMA’s next Global Teleconference Thursday, March 19, 2009 Featuring presentations by Medical Research Council’s Dr. Sheena McCormack (UK – on left), UCLA’s Dr. Peter Anton (center) and Dr. Ian McGowan, University of Pittsburgh (right). Be among the first to know about upcoming rectal microbicide trials – including rectal safety studies of tenofovir and Pro2000 – from the Read More >>

    Dr. Ian McGowan, Dr. Peter Anton, Dr. Sheena McCormack, IRMA, rectal microbicide, safety, teleconference
  4. Rectal Microbicide Research at CROI 2009

    The prevalence of receptive anal intercourse among men and women the world over requires the research and development of safe, effective and acceptable microbicides designed specifically for the rectum as well. Today at CROI 2009, two interesting Poster Discussions were held of special interest to IRMA members. You can access the abstracts and actual posters for each Read More >>

    anal sex, CROI, Dr. Ian McGowan, Dr. Peter Anton, rectal microbicide, research, vaginal microbicide
  5. “Beginning to Cross the Rectal Rubicon”

    Join IRMA for a Global Teleconference Thursday, May 29, 2008 Dr. Peter Anton will present a summary review of the data presented at M2008 on the first IND-supported rectal microbicide Phase 1 trial (using UC781). The talk will highlight explanations of the various mucosal assays currently in use, the design issues confronted and blinded results, now that Read More >>

    Dr. Peter Anton, IRMA, rectal microbicide, teleconference